Skip to main content

NIPER Recruitment : Opportunities for Life Sciences or Pharmacy Candidates

Post Graduate degree in Public Health/ Statistics/ Epidemiology/Health Sciences/ Life Sciences/ Environmental Sciences/ HTA/ Population Sciences/ Life Sciences/ Pharmaceutical Sciences/ Demography/ Health Economics/M. Pharma (Pharmacy Practice/ Clinical Research/Pharmacology/ Nursing).
Government Scientific Positions Open for Pharmacy or Science Candidates under staff selection commission
Bachelors / Masters degree in Science or Pharmacy or Pharmaceutical Chemistry or Medicine from a University recognized by the Government of India or an equivalent qualification OR Have a Masters degree in Medicine or Science or Pharmacy or Pharmaceutical Chemistry from a University recognized by the Government of India.
Interview for Pharmacist at Homi Bhabha Cancer Hospital and Research Centre
Diploma in Pharmacy from a recognized institution and registered as pharmacist OR Bachelor Degree in Pharmacy (B. Pharm) from a recognized institution and registered as Pharmacist under the Pharmacy act 1948 and one year experience as pharmacist in any recognized hospital or pharmacy after registration as pharmacist under the Pharmacy act 1948.
Applications are invited for the post of Pharmacist in District Health Society
Must have a degree in Pharmacy/Diploma in Pharmacy from a recognized university.Must be registered with Pharmacy Council Board and should be current.Must have basic computer knowledge.
Advertisement for Pharmacist in ECHS Polyclinic Kotdwara and Pauri
Pharmacy from a recognized Institute Or 10+2 with Science stream (Physics Chemistry, Biology) from a recognized Board and approved Diploma in Pharmacy from an Institute recognized by the Pharmacy Council of India and registered as Pharmacist under the Pharmacy Act 1948
Life Science, Biochemistry, Biotechnology Fellowships at Banaras Hindu University
The candidate should have a first-class post-graduate degree in Biochemistry / Biotechnology / Molecular & Human Genetics /Zoology / Animal Science / Life Sciences with qualified CSIR-UGC NET/GATE.
Advertisement for Biochemistry / Microbiology / Biotechnology / Chemistry candidates at Panjab University
M.Sc. in Biophysics/Biochemistry/Microbiology/Biotechnology/Chemistry/allied subjects with minimum 55% marks. Candidates with UGC-NET/GATE/PU PhD (Biophysics)/ other national entrance test conducted by Government of India will be preferred.
Online PhD Walk-in Interview at National Institute of Animal Biotechnology
Candidates must have a Master's degree (M.Sc./M.Tech./M.V.Sc./M.Pharm. or M.B.B.S or B. Tech. degree) in any branch of Life Sciences with a consistently good academic record. 
BITS Fellowships for Professional Course candidates
Post Graduate Degree in Basic Science OR Graduate/Post Graduate in Degree in Professional Course selected through National Eligibility Tests- CSIR –UGC NET including lectureship (Assistant Professorship) and GATE. 
BRIC-NABI requires Life Sciences / Biotechnology research personnel
Post graduate degree in any branch of life sciences /biotechnology or Graduate/Post Graduate in any branch of life sciences or biotechnology or Post Graduate in any branch of life sciences /biotechnology selected through National Eligibility Tests-CSIR UGC NET including Lectureship (Assistant Professorship) and GATE.
INTERVIEW FOR PhD August 2026 SESSION at INST Mohali
A minimum of 60% marks (or CPI of 6.00) at Masters level AND Candidates should have valid GATE/GPAT/CSIR or UGC-NET/JEST/JGEEBILS (TIFR/NCBS)/ICMR-JRF/ICAR-NET/ DBT-JRF/ Project - Funded (as per INST rules)/ DST-INSPIRE will be adhoc basis subject to successful activation of inspire fellowship.
Brainstorming Session Organized by Indian Pharmacopoeia Commission in collaboration with Yashoda Medicity

The Govt. of India have created a separate, dedicated, autonomous institution in the form of the Indian Pharmacopoeia Commission (IPC) to deal with matters relating to timely publication of the Indian Pharmacopoeia which is the official book of standards for drug included therein, in terms of the Second Schedule to the Drugs and Cosmetics Act, 1940 so as to specify the standards of identify, purity and strength of the drugs imported, manufactured for sale, stocked or exhibited for sale or distributed in India.

Join Sun Pharma as Pharmacokinetics Senior Executive
Sun Pharma invites positions in Pharmacokinetics. Literature search and study designing of Bioavailability and Bioequivalence studies of oral & non-oral products towards different regulatory submission.
Aurigene looking for Talent Acquisition professional to lead
MBA / Postgraduates in HR with 8-10 years of experience in Talent Acquisition, preferably within the Pharmaceutical, Biotechnology, Life sciences, or Healthcare sectors.
Walk In Drive for Pharma and Science candidates in Production, Technology Transfer, QA and QC at USV
USV Private Limited is a prominent Indian multinational pharmaceutical and biotechnology company founded in 1961, specializing in diabetes and cardiovascular therapeutics
Sun Pharma Hiring Quality Assurance Sr. Officer
To review the complaint investigation, ensure closure, notification to the complainant and ensure the implementation of the CAPA with its effectiveness.
Production Junior Officer Require at Cipla | BPharm Apply
Monitor and execute the production activities in an area during the shift by maintaining cGMP and safety norms to achieve production targets
Clinical Research Coordinator Job at HRAPL
Hiring a Clinical Research Coordinator with 2-3 years of experience to manage daily site activities, patient workflows, and accurate documentation. The role requires strong coordination, attention to detail, and strict protocol compliance to ensure smooth, high-quality clinical operations.
Work as Manufacturing In-charge at Sun Pharma
To co-ordinate with purchase department for status of purchase order and delivery of consignment from supplier as when required.
Merck’s Tulisokibart Clears Key Phase 3 Hurdle, Raising Hopes for Ulcerative Colitis Patients

Merck & Co. has announced positive topline results from the Phase 3 ATLAS-UC induction-only study evaluating its investigational anti-TL1A monoclonal antibody tulisokibart in patients with moderately to severely active ulcerative colitis (UC).

According to the company, the study successfully achieved both its primary endpoint and key secondary endpoints, marking an important milestone in the development of a potential new treatment option for patients living with the chronic inflammatory bowel disease.

Subscribe to